Literature DB >> 16032

Epidemiological studies of Streptococcus pneumoniae in infants: methods of isolating pneumococci.

G M Converse, H C Dillon.   

Abstract

A prospective study of the natural history of pneumococcal infection, which involves serial culture studies in healthy infants from 6 weeks of age onward, is in progress in our laboratory. This report describes results of a comparison of several methods for the isolation and identification of Streptococcus pneumoniae from the nasopharynges and throats of these infants. Sheep blood agar, sheep blood agar with gentamicin sulfate (gentamicin agar), and mouse inoculation with 4-h broth cultures were used. Gentamicin agar proved superior to plain sheep blood agar as a solid culture medium, especially in enhancing the recovery of pneumococci from throat cultures. With gentamicin agar, similar carrier rates were found for both culture sites (nasopharynx and throat). In addition, gentamicin agar proved superior to mouse inoculation for the recovery of carrier strains from 131 nasopharyngeal culture samples processed by both methods. Sixty of 131 samples were positive for pneumococci, 25% of which would have been missed had mouse inoculation alone been used. In only three instances did we recover a strain by mouse inoculation that failed to grow on gentamicin agar; conversely, 15 strains were isolated on gentamicin agar but could not be recovered from mice. The latter observation might be explained by the fact that certain carrier strains may be relatively mouse avirulent. The use of blood agar containing gentamicin appears to offer a simple and inexpensive method for the recovery of S. pneumoniae and, in our opinion, provides an ideal method for the identification of pneumococcal carriers as well as for the recovery of these strains from clinical material such as sputum or ear exudates, where other and less fastidious organisms may also be present.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16032      PMCID: PMC274585          DOI: 10.1128/jcm.5.3.293-296.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Laboratory diagnosis of Pneumococcus infections.

Authors:  E LUND
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

2.  Bacterial flora of the upper respiratory tract in Paddington families. 1952-4.

Authors:  P L MASTERS; W BRUMFITT; R L MENDEZ; M LIKAR
Journal:  Br Med J       Date:  1958-05-24

3.  Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children.

Authors:  F A Loda; A M Collier; W P Glezen; K Strangert; W A Clyde; F W Denny
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

4.  Pharyngeal pneumococcal acquisitions in "normal" families: a longitudinal study.

Authors:  J N Dowling; P R Sheehe; H A Feldman
Journal:  J Infect Dis       Date:  1971-07       Impact factor: 5.226

5.  Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types.

Authors:  J O Hendley; M A Sande; P M Stewart; J M Gwaltney
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

6.  The prevalence of pneumococcal types and the continuing importance of pneumococcal infection.

Authors:  R AUSTRIAN
Journal:  Am J Med Sci       Date:  1959-08       Impact factor: 2.378

  6 in total
  21 in total

1.  Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.

Authors:  Y i Hwang; M H Nahm; D E Briles; D Thomas; J M Purkerson
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.

Authors:  Evida A Dennis; Mamie T Coats; Sarah Griffin; Bing Pang; David E Briles; Marilyn J Crain; W Edward Swords
Journal:  Pathog Dis       Date:  2018-10-01       Impact factor: 3.166

4.  Survival of Streptococcus pneumoniae in sputum from patients with pneumonia.

Authors:  S G Williams; C A Kauffman
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

5.  Pneumococcal carriage amongst Australian aborigines in Alice Springs, Northern Territory.

Authors:  D Hansman; S Morris; M Gregory; B McDonald
Journal:  J Hyg (Lond)       Date:  1985-12

6.  Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci.

Authors:  David E Briles; Lea Novak; Muneki Hotomi; Frederik W van Ginkel; Janice King
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Evaluation of sampling sites for detection of upper respiratory tract carriage of Streptococcus pneumoniae and Haemophilus influenzae among healthy Filipino infants.

Authors:  M R Capeding; H Nohynek; L T Sombrero; L G Pascual; E S Sunico; G A Esparar; E Esko; M Leinonen; P Ruutu
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  Nasopharyngeal carriage of pneumococci in children with sickle cell disease.

Authors:  G D Overturf; R Field; C Lam; S Lee; D R Powars
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

9.  Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study.

Authors:  C J Gill; V Mwanakasale; M P Fox; R Chilengi; M Tembo; M Nsofwa; V Chalwe; L Mwananyanda; D Mukwamataba; B Malilwe; D Champo; W B Macleod; D M Thea; D H Hamer
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

10.  Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women.

Authors:  C J Gill; V Mwanakasale; M P Fox; R Chilengi; M Tembo; M Nsofwa; V Chalwe; L Mwananyanda; D Mukwamataba; B Malilwe; D Champo; W B Macleod; D M Thea; D H Hamer
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.